Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,173.9
9.1 (0.29%)

 

  • STI Straits Times Index
    3,173.9
    9.1 (0.29%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,598.3
    5.8 (0.36%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,331.0
    368.4 (1.48%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,572.4
    14.1 (0.40%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,068.6
    517.7 (1.81%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,633.3
    7.2 (0.11%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,492.6M
  • Value: 1,237.8M
  • Rise: 199
  • Fall: 127
  • Unch: 425

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.079+0.009
Rex Intl0.310+0.005
Genting Sing0.795+0.015
Ntegrator Intl0.009-
Geo Energy Res0.410-0.010
RH PetroGas0.205-
Sembcorp Marine0.080-
MarcoPolo Marine0.028-0.001
BlackGoldNatural0.019-
ThaiBev0.715+0.005

World Indices

World Indices
Name Last Change
Nasdaq 14,897.3 +73.9
HSI 25,331.0 +368.4
HSCEI 8,966.2 +117.0
Jakarta 6,633.3 +7.2
Nikkei 225 29,068.6 +517.7
SSE Comp 3,572.4 +14.1
Shanghai A 3,743.9 +14.8
Shanghai B 278.0 +0.5
KOSPI 3,015.1 +26.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ZYMEWORKS INC ZYMEWORKS
Updated on 15 Oct 2021 (End of trading day)
Last (USD): 25.940 Change: +1.200 High: 27.105 Remarks: -
Change (%): +4.85 Low: 24.990
Open 25.050 Yesterday's Close 24.740000000000002
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 701,557 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -3.89241 Trailing EPS (USD) e -4.79818 NAV (USD) b 6.9304
PE a - Trailing PE f - Price / NAV b 3.7429
Dividend (USD) d - Cash In Hand (USD) g 5.5439 Issued & Paid-up Shares c 46,385,700
Dividend Yield (%) d - Price / Cash In Hand g 4.679 Treasury Shares h -
Market Cap (M) 1,203.245 Enterprise Value (M) 875.277
Piotroski F Score 2 Exchange Code ZYME Par Value ( $ ) n.a.
52 Weeks Volatility (%) 74.51 Free Float (%) 98.5
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 05 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 24 Apr 2017.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ZYMEWORKS INC NYSE 1,203.245 - - 3.7429 -
Industry Pharmaceuticals: Major NYSE 115,191.820 32.850 27.572 5.4139 2.082
Local Peer JOHNSON & JOHNSON NYSE 424,619.024 28.858 23.899 6.1026 2.467
Local Peer PFIZER INC NYSE 232,621.568 24.191 17.586 3.3212 3.662
Local Peer ELI LILLY AND COMPANY NYSE 227,551.488 36.739 37.484 35.3100 1.244
Local Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 202,860.219 24.982 22.555 3.7538 2.313
Local Peer MERCK & CO INC NYSE 198,282.212 28.057 35.592 5.9555 3.165
Local Peer ABBVIE INC NYSE 193,205.789 42.407 29.322 15.3715 4.422
Local Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 181,403.790 28.152 25.482 17.3508 1.314
Local Peer BRISTOL-MYERS SQUIBB CO NYSE 129,682.340 - - 3.5232 3.184
Local Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 98,144.089 13.313 16.547 4.6202 5.304
Local Peer TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS NYSE 44,619.591 12.586 11.049 0.9454 5.434
Local Peer BIOHAVEN PHARMACEUTICAL HLDG CO LTD NYSE 8,738.254 - - -19.2524 -
Local Peer ORGANON & CO NYSE 8,846.185 4.095 4.095 -4.5741 -
Other Local Peers EMERGENT BIOSOLUTIONS INC (NYSE), ADC THERAPEUTICS SA (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), LANNETT CO INC (NYSE)
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 186,577.819 58.379 49.477 11.9021 1.928
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 123,441.019 8.794 17.825 1.6460 2.738
Global Peer WUXI APPTEC CO LTD HKEx 488,672.596 147.237 105.525 11.0692 0.213
Global Peer ROYALTY PHARMA PLC NASDAQ 23,309.333 23.906 23.992 4.0653 0.500
Global Peer VIATRIS INC NASDAQ 16,277.043 - - 0.7675 -
Global Peer HANSOH PHARMACEUTICAL GROUP CO LTD HKEx 121,704.292 42.161 39.386 5.4097 0.375
Global Peer REPLIGEN CORP NASDAQ 14,674.514 244.876 146.844 9.1540 -
Global Peer INNOVENT BIOLOGICS INC HKEx 111,944.480 - - 7.8235 -
Global Peer CANSINO BIOLOGICS INC HKEx 72,142.320 - 91.601 8.5549 -
Global Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 9,083.592 - - 11.1415 -
Other Global Peers CUREVAC NV (NASDAQ), SINOPHARM GROUP CO. LTD. (HKEx), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), REMEGEN CO LTD (HKEx), ALLAKOS INC (NASDAQ), SHANGHAI PHARMACEUTICALS HOLDING CO (HKEx), HYGEIA HEALTHCARE HLDGS CO LTD (HKEx), HUTCHMED (CHINA) LIMITED (HKEx), HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), SHANGHAI JUNSHI BIOSCIENCES CO LTD (HKEx), AKESO INC (HKEx), CHINA MEDICAL SYSTEM HLDGS LTD (HKEx), GUANGZHOU BAIYUNSHAN PHARMACEUTICAL (HKEx), INNOCARE PHARMA LTD (HKEx), IMMUNITYBIO INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), CHINA RESOURCES PHARMACEUTICAL GR (HKEx), SPRINGWORKS THERAPEUTICS INC (NASDAQ), CARSGEN THERAPEUTICS HLDGS LTD (HKEx), CHINA GRAND PHARMACEUTICAL & HEALTH (HKEx), OPKO HEALTH INC (NASDAQ), SIMCERE PHARMACEUTICAL GRP LTD (HKEx), TURNING POINT THERAPEUTICS INC (NASDAQ), CHINA TRADITIONAL CHINESE MED HLDGS (HKEx), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ERASCA INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), SHANGHAI HENLIUS BIOTECH INC (HKEx), EVEREST MEDICINES LTD (HKEx), SHENZHEN HEPALINK PHARMACEUTICAL (HKEx), DICERNA PHARMACEUTICALS INC. (NASDAQ), OCUMENSION THERAPEUTICS (HKEx), SSY GROUP LIMITED (HKEx), CSTONE PHARMACEUTICALS (HKEx), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENERATION BIO CO (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), UNITED LABORATORIES INTL HLDGS LTD (HKEx), OLEMA PHARMACEUTICALS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), ABBISKO CAYMAN LTD (HKEx), Kimia Farma Tbk. (IDX), BEIJING TONG REN TANG CHINESE MEDIC (HKEx), FULCRUM THERAPEUTICS INC (NASDAQ), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), PROCAPS GROUP S A (NASDAQ), IMMUNOTECH BIOPHARM LTD (HKEx), CULLINAN ONCOLOGY INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), ICOSAVAX INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), KRONOS BIO INC (NASDAQ), SCICLONE PHARMACEUTICALS (HLDGS) LT (HKEx), ANTENGENE CORP LTD (HKEx), FORMA THERAPEUTICS HLDGS INC (NASDAQ), CK LIFE SCIENCES INTL HLDG (HKEx), SUTRO BIOPHARMA INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), TRANSCENTA HOLDING LTD (HKEx), PRAXIS PRECISION MEDICINES INC (NASDAQ), GH RESEARCH PLC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), ANNEXON INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), PETIQ INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), CHINA SHINEWAY PHARMACEUTICAL GR (HKEx), VERU INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), HUA MEDICINE (HKEx), SIGA TECHNOLOGIES INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), PHARVARIS NV (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), ZHAOKE OPHTHALMOLOGY LTD (HKEx), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), Soho Global Health Tbk. (IDX), APPLIED THERAPEUTICS INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), AC IMMUNE SA (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), IGBB (Bursa), EVOLUS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), CLENE INC (NASDAQ), PYXIS ONCOLOGY INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), 89BIO INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), ESSA PHARMA INC (NASDAQ), RACE ONCOLOGY LTD (ASX), VERRICA PHARMACEUTICALS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), DAWNRAYS PHARMACEUTICAL HLDGS (HKEx), TOT BIOPHARM INTL CO LTD (HKEx), EYEPOINT PHARMACEUTICALS INC (NASDAQ), CYBIN INC (NYSE American), FUSION PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), ATHENEX INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), NEXIMMUNE INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), XOMA CORP (NASDAQ), BSTEAD (Bursa), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), CHECKPOINT THERAPEUTICS INC (NASDAQ), DURECT CORP (NASDAQ), HARROW HEALTH INC (NASDAQ), FUSEN PHARMACEUTICAL CO LTD (HKEx), PHARMA (Bursa), VINCERX PHARMA INC (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ANNOVIS BIO INC (NYSE American), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), TRICIDA INC (NASDAQ), OBSEVA SA (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), IMMUNIC INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), MUSTANG BIO INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), ALZAMEND NEURO INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), IP (SET), SCPHARMACEUTICALS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), POLYPID LTD (NASDAQ), NOVAN INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), CHINA BIOTECH SERVICES HLDGS LTD (HKEx), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), EYENOVIA INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), IX Biopharma (SGX), ETON PHARMACEUTICALS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), ZHONGZHI PHARMACEUTICAL HLDGS LTD (HKEx), NOXOPHARM LTD (ASX), CYCLERION THERAPEUTICS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), Merck Tbk. (IDX), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), KOTRA (Bursa), CRESO PHARMA LTD (ASX), LYRA THERAPEUTICS INC (NASDAQ), IMARA INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), CHARMACY PHARMACEUTICAL CO LTD (HKEx), YUMANITY THERAPEUTICS INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), NEW RAY MEDICINE INTL HLDG LTD (HKEx), GALECTO INC (NASDAQ), PROPHASE LABS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), GRAYBUG VISION INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), Phapros Tbk. (IDX), ALLENA PHARMACEUTICALS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), PAK FAH YEOW INTERNATIONAL (HKEx), SANAI HEALTH INDUSTRY GP CO LTD (HKEx), Hyphens Pharma (SGX), NOVA (Bursa), EXOPHARM LTD (ASX), VYNE THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), NEW CENTURY HEALTHCARE HLDGS CO LTD (HKEx), INVION LTD (ASX), ABVC BIOPHARMA INC (NASDAQ), BIOHLDG (Bursa), BONE BIOLOGICS CORP (NASDAQ), VIRPAX PHARMA INC (NASDAQ), MODERN CHINESE MEDICINE GRP CO LTD (HKEx), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), SHENZHEN NEPTUNUS INTERLONG BIO-TEC (HKEx), UNIVERSE PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), RENOVORX INC (NASDAQ), WAI YUEN TONG MEDICINE HOLDINGS LTD (HKEx), BAUDAX BIO INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), SEQLL INC (NASDAQ), PURAPHARM CORPORATION LIMITED (HKEx), CNS PHARMACEUTICALS INC (NASDAQ), PHARMAXIS (ASX), VIRIOS THERAPEUTICS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), MEDLAB CLINICAL LIMITED (ASX), PASITHEA THERAPEUTICS CORP (NASDAQ), PALLA PHARMA LTD (ASX), ACER THERAPEUTICS INC (NASDAQ), AGEX THERAPEUTICS INC (NYSE American), JCT (SET), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), EXTRAWELL PHARMACEUTICAL HLDGS (HKEx), XORTX THERAPEUTICS INC (NASDAQ), SUNZEN (Bursa), HOTH THERAPEUTICS INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), TIMBER PHARMACEUTICALS INC (NYSE American), PANBELA THERAPEUTICS INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), ACRUX (ASX), IMMURON LIMITED (ASX), AVENUE THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), NANJING SINOLIFE UNITED COMPANY LTD (HKEx), TALI DIGITAL LIMITED (ASX), ISLAND PHARMACEUTICALS LTD (ASX), TELIGENT INC NEW (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), SUDA PHARMACEUTICALS LTD (ASX), PETROS PHARMACEUTICALS INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), PA SHUN INTERNATIONAL HOLDINGS LTD (HKEx), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.350
+5.49 %
10 Days --3.390
-11.56 %
20 Days --9.710
-27.24 %
Medium Term Return 3 Months --9.790
-27.40 %
6 Months --4.440
-14.61 %
1 Year --20.020
-43.56 %
Long Term Return 2 Years --3.680
-12.42 %
3 Years -+13.190
+103.45 %
Annualised Return Annualised --
+26.71 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 24.410 - 59.030 Change From 1 Year Low +1.530 % Change From 1 Year Low (%) +6.27
Change From 1 Year High -33.090 % Change From 1 Year High (%) -56.06
2 Years Range 20.330 - 59.030 Change From 2 Years Low +5.610 % Change From 2 Years Low (%) +27.59
Change From 2 Years High -33.090 % Change From 2 Years High (%) -56.06
5 Years Range 6.250 - 59.030 Change From 5 Years Low +19.690 % Change From 5 Years Low (%) +315.04
Change From 5 Years High -33.090 % Change From 5 Years High (%) -56.06
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Zymeworks, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.

Historical Price Data

Date Open High Low Close Volume VWAP
15 Oct 2021 25.050 27.105 24.990 25.940 701,557 -
14 Oct 2021 25.670 25.810 24.690 24.740 2,467,789 -
13 Oct 2021 25.550 25.680 25.150 25.290 290,021 -
12 Oct 2021 25.670 26.355 25.280 25.540 220,434 -
11 Oct 2021 24.420 25.850 24.420 25.660 269,291 -
08 Oct 2021 26.440 26.780 24.410 24.590 549,291 -
07 Oct 2021 27.670 28.520 26.320 26.420 388,976 -
06 Oct 2021 27.880 28.890 27.680 28.070 413,794 -
05 Oct 2021 28.940 29.160 26.920 28.080 1,403,996 -
04 Oct 2021 28.870 29.080 27.230 28.770 528,199 -
01 Oct 2021 29.040 29.620 28.525 29.330 446,007 -
30 Sep 2021 27.410 29.080 27.350 29.040 953,683 -
29 Sep 2021 29.810 29.810 27.120 27.350 497,933 -
28 Sep 2021 29.360 30.180 29.120 29.700 315,335 -
27 Sep 2021 28.360 30.150 28.040 29.610 460,775 -
24 Sep 2021 29.420 29.710 28.130 28.520 589,599 -
23 Sep 2021 31.390 31.700 29.150 29.760 843,540 -
22 Sep 2021 31.100 31.990 30.510 31.100 314,847 -
21 Sep 2021 33.380 33.840 30.830 30.850 340,995 -
20 Sep 2021 34.660 35.180 33.010 33.070 375,466 -
17 Sep 2021 36.660 37.190 35.090 35.650 800,866 -
16 Sep 2021 36.500 37.000 34.060 36.100 1,958,648 -
Summary
Current 2 Weeks
(04 Oct 2021 to 15 Oct 2021)
28.870 29.160 24.410 25.940 7,233,348 -
Previous 2 Weeks
(20 Sep 2021 to 01 Oct 2021)
34.660 35.180 24.410 29.330 5,138,180 -
4 Weeks from
(20 Aug 2021 to 17 Sep 2021)
30.650 31.810 24.410 35.650 10,213,158 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.